Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (171-180 of 241) with videos related to

Pageof 25
Sort By:
Healthcare (Basel, Switzerland)|September 27, 2025
Relationship Between Oral Function and Social Participation Among Community-Dwelling Older Adults: An Observational Cross-Sectional StudyMayu Takeda, Yuhei Matsuda, Takafumi Abe, et al.
The Oncologist|October 18, 2017
Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind TrialHiroaki Tsukuura, Masayuki Miyazaki, Tatsuya Morita, et al.
International Cancer Conference Journal|March 25, 2024
Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature reviewFutoshi Ushijima, Tetsunari Hase, Yuki Yamashita, et al.
Anti-Cancer Drugs|February 6, 2003
Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasmsSuoping Zhai, Edward A Sausville, Adrian M Senderowicz, et al.
Cancer Science|October 25, 2018
Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcomaKan Yonemori, Makoto Kodaira, Taroh Satoh, et al.
Circulation Reports|September 11, 2025
Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated With Trastuzumab and PertuzumabReina Ozaki, Ryota Morimoto, Shingo Kazama, et al.
Cancer Science|July 29, 2016
Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumorsHironobu Minami, Yuichi Ando, Brigette Buig Yue Ma, et al.
Cancer Science|October 2, 2015
Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancerNaomi Kiyota, Martin Schlumberger, Kei Muro, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 4, 2024
Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity teamTakanori Ito, Kazuyuki Mizuno, Takafumi Yamamoto, et al.
Cancer Science|October 8, 2020
Phase I study of the antiprogrammed cell death-1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignanciesHironobu Minami, Toshihiko Doi, Masanori Toyoda, et al.
Pageof 25

Showing results (171-180 of 241) with videos related to

Sort By:
Pageof 25
Healthcare (Basel, Switzerland)|September 27, 2025
Relationship Between Oral Function and Social Participation Among Community-Dwelling Older Adults: An Observational Cross-Sectional StudyMayu Takeda, Yuhei Matsuda, Takafumi Abe, et al.
The Oncologist|October 18, 2017
Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind TrialHiroaki Tsukuura, Masayuki Miyazaki, Tatsuya Morita, et al.
International Cancer Conference Journal|March 25, 2024
Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature reviewFutoshi Ushijima, Tetsunari Hase, Yuki Yamashita, et al.
Anti-Cancer Drugs|February 6, 2003
Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasmsSuoping Zhai, Edward A Sausville, Adrian M Senderowicz, et al.
Cancer Science|October 25, 2018
Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcomaKan Yonemori, Makoto Kodaira, Taroh Satoh, et al.
Circulation Reports|September 11, 2025
Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated With Trastuzumab and PertuzumabReina Ozaki, Ryota Morimoto, Shingo Kazama, et al.
Cancer Science|July 29, 2016
Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumorsHironobu Minami, Yuichi Ando, Brigette Buig Yue Ma, et al.
Cancer Science|October 2, 2015
Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancerNaomi Kiyota, Martin Schlumberger, Kei Muro, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 4, 2024
Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity teamTakanori Ito, Kazuyuki Mizuno, Takafumi Yamamoto, et al.
Cancer Science|October 8, 2020
Phase I study of the antiprogrammed cell death-1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignanciesHironobu Minami, Toshihiko Doi, Masanori Toyoda, et al.
Pageof 25